Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacologic Optimization of Voriconazole - a Prospective Clustered Group-randomized Cross-over Trial of Therapeutic Drug Monitoring

NCT00893555 is registered in ClinicalTrials.gov with Jan-Willem C Alffenaar as lead sponsor.

NCT NCT00893555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00893555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacologic Optimization of Voriconazole - a Prospective Clustered Group-randomized Cross-over Trial of Therapeutic Drug Monitoring
Lead sponsor
Jan-Willem C Alffenaar
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2009
Completion date
January 31, 2017
Enrollment
189 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancy, invasive fungal infection